Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AIDS (London)

• Publication date

  2005-09-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.aids.0000181008.39514.eePMID 16103765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection

  2011cited by this paper
• HIV-associated cognitive impairment before and after the advent of combination therapy

  2011cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Flow cytometric analysis of vaccine responses: how many colors are enough?

  2004cited by this paper
• Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection

  2004cited by this paper
• Chemokines in the pathogenesis of vascular disease.

  2004cited by this paper
• HIV‐1 expression protects macrophages and microglia from apoptotic death

  2004cited by this paper
• Multinucleated giant cells in brain: A hallmark of the acquired immune deficiency syndrome (AIDS)

  2004cited by this paper
• The quantity and diversity of infectious viruses in various tissues of SHIV-infected monkeys at the early and AIDS stages

  2004cited by this paper
• Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection

  2004cited by this paper
• Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era

  2003cited by this paper
• Epidemiology of HIV cardiac disease.

  2003cited by this paper
• Chemokine Receptor 2 (CCR2) in Atherosclerosis, Infectious Diseases, and Regulation of T‐Cell Polarization

  2003cited by this paper
• HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.

  2003influential reference
• Management of Anemia of Chronic Disease in Patients with the Human Immunodeficiency Virus

  2003cited by this paper
• Ischaemic Cerebrovascular Events in HIV Infection

  2003cited by this paper
• Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen.

  2003cited by this paper
• Ischaemic cerebrovascular events in HIV infection: a cohort study.

  2003cited by this paper
• Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease?

  2003cited by this paper
• Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

  2003cited by this paper
• [Atherosclerosis in HIV-positive patients].

  2002cited by this paper
• Arteriosklerose bei HIV-positiven Patienten

  2002cited by this paper
• Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis?

  2002cited by this paper
• Insights into the role of immune activation in HIV neuropathogenesis

  2002cited by this paper
• Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia

  2002cited by this paper
• CD36 deficiency induced by antiretroviral therapy

  2002influential reference
• Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo *

  2002cited by this paper
• Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.

  2002cited by this paper
• HIV‐Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy

  2002cited by this paper
• HIV-associated neurologic disease incidence changes:

  2001cited by this paper
• Nursing Home Residents with HIV and Anemia

  2001cited by this paper
• Oxidant stress as a marker for cardiovascular events: Ox marks the spot.

  2001cited by this paper
• Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

  2001cited by this paper
• Cardiomyopathy and Encephalopathy in AIDS

  2001cited by this paper
• Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.

  2001cited by this paper
• Changes in pathological findings at autopsy in AIDS cases for the last 15 years

  2000cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• Progressive Stroke in an HIV-1-Positive Patient under Protease Inhibitors

  2000cited by this paper
• Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)

  2000cited by this paper
• HIV Infection and Dementia

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association wi

  1999cited by this paper
• Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.

  1999cited by this paper
• Influence of protease inhibitor therapy on lipoprotein metabolism

  1999cited by this paper
• Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function.

  1999influential reference
• Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL.

  1998influential reference
• Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV‐infected persons

  1998cited by this paper
• An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

  1998cited by this paper
• Tubular Cell and HIV-1 gp120 Interaction Products Promote Migration of Monocytes

  1998cited by this paper
• Phosphatidylinositol 3-Kinase Is Involved in the Induction of Macrophage Growth by Oxidized Low Density Lipoprotein*

  1998cited by this paper
• Unique monocyte subset in patients with AIDS dementia.

  1997cited by this paper
• Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36*

  1997cited by this paper
• Low Density Lipoprotein Oxidation and Its Pathobiological Significance*

  1997cited by this paper
• HIV-associated stroke: report of two unusual cases.

  1996cited by this paper
• Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis.

  1996cited by this paper
• Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

  1996cited by this paper
• Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.

  1996cited by this paper
• Hyperinsulinism and cerebral microangiopathy.

  1996cited by this paper
• Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia

  1995cited by this paper
• Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion.

  1995cited by this paper
• Dementia in AIDS patients

  1993cited by this paper
• Human Kupffer cells infected with HIV-1 in vivo.

  1993cited by this paper
• Free-radical generation by monocytes and neutrophils: a possible cause of plasma lipoprotein modification.

  1991cited by this paper
• Postprandial Effect of a High Fat Meal on Plasma Lipid, Lipoprotein Cholesterol and Apolipoprotein Measurements

  1990cited by this paper
• Report of two unusual cases.

  1951cited by this paper

• Differential tissue and cellular distribution of chemokine C-C motif ligand 2 in grey/white matters of healthy and simian immunodeficiency virus infected monkey.

  2025cites this paper
• Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder

  2020influential citation
• AIDS-Defining Malignancies and HAART

  2017cites this paper
• Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR

  2015cites this paper
• Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects

  2013cites this paper
• Different Levels of HIV DNA Copy Numbers in Cerebrospinal Fluid Cellular Subsets

  2013cites this paper
• Cell trafficking through the choroid plexus

  2012cites this paper
• Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders

  2011cites this paper
• Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study

  2011cites this paper
• Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy

  2009cites this paper
• The neuropathology of HIV pre- and post-HAART.

  2009cites this paper
• Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

  2008cites this paper
• Biomarkers of HIV related central nervous system disease

  2008cites this paper
• Disease Risk Factors Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular

  2008cites this paper
• Non-AIDS-defining malignancies and HAART.

  2007cites this paper
• Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals

  2007cites this paper
• The CD14+ CD16+ blood monocytes: their role in infection and inflammation

  2007cites this paper
• Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

  2007cites this paper
• Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy.

  2006cites this paper